By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Takeda California 

Takeda San Diego
10410 Science Center Drive
San Diego  California  92121  U.S.A.
Phone: 858-622-8528 Fax: 858-550-0526



Company News
Samsung Bioepis Forms Novel Biologics JV With Takeda Pharmaceuticals 8/23/2017 8:09:31 AM
California Life Sciences Association Adds Leaders From Covington & Burling And Takeda Pharmaceuticals To Board Of Directors 5/8/2017 10:57:37 AM
Tri-Institutional Therapeutics Discovery Institute Expands Partnership With Takeda Pharmaceuticals 6/17/2016 8:48:30 AM
Takeda Pharmaceuticals Release: Brintellix (Vortioxetine) Renamed Trintellix (Vortioxetine) In U.S. To Avoid Name Confusion 5/3/2016 6:07:57 AM
Takeda Pharmaceuticals Release: European Medicines Agency Grants Accelerated Assessment Of Ixazomib For Patients With Relapsed/Refractory Multiple Myeloma 7/27/2015 10:50:00 AM
Takeda Pharmaceuticals’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation By U.S. FDA For Relapsed Or Refractory Systemic Light-Chain Amyloidosis 12/1/2014 10:21:24 AM
Takeda Pharmaceuticals President Doug Cole Quits 11/21/2014 5:59:21 AM
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014 8:22:26 AM
Takeda Pharmaceuticals And Lundbeck Inc. (LUN.CO) Announce Brintellix® (Vortioxetine) For The Treatment Of Major Depressive Disorder In Adults Is Now Available In Pharmacies 1/23/2014 10:46:15 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Deerfield Campus Among Chicago Tribune's 2013 Top 100 Workplaces 11/14/2013 12:04:45 PM